Skip to main navigation Skip to search Skip to main content

Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial.

  • Jean-Louis Vincent
  • , Bruno Francois
  • , Igor Zabolotskikh
  • , Mradul Kumar Daga
  • , Jean-Baptiste Lascarrou
  • , Mikhail Y. Kirov
  • , Ville Pettila
  • , Xavier Wittebole
  • , Ferhat Meziani
  • , Emmanuelle Mercier
  • , Suzana M. Lobo
  • , Philip S. Barie
  • , Mark Crowther
  • , Charles T. Esmon
  • , Jawed Fareed
  • , Satoshi Gando
  • , Kenneth J. Gorelick
  • , Marcel Levi
  • , Jean-Paul Mira
  • , Steven M. Opal
  • Joseph Parrillo, Joseph Parrillo, James A. Russell, Hidehiko Saito, Kazuhisa Tsuruta, Takumi Sakai, David Fineberg, Romina Bertuzzi, Rinaldo Bellomo, Marianne Chapman, David Ernest, Jason Fletcher, Craig French, John Gowardman, Yahya Shehabi, Bala Venkatesh, James Walsham, Sanjiv Vij, Didier Chochrad, Jacques Creteur, Jacques Devriendt, Alain-Michel Dive, Thierry Dugernier, Frederic Foret, Eric Hoste, Philippe Jorens, Marc Simon, Herbert Spapen, Fernando Dias, Kenneth E. Krell
  • Universite Libre de Bruxelles
  • French Institute of Health and Medical Research
  • Kuban State Medical University
  • Maulana Azad Medical College
  • University of Helsinki
  • Université catholique de Louvain
  • University of Strasbourg
  • Hospital de Base
  • Cornell University
  • St Joseph Hospital
  • Oklahoma Medical Research Foundation
  • Loyola University Medical Center
  • University College London
  • Paris Descartes University
  • Rhode Island Hospital
  • Rutgers University
  • Hackensack University Medical Center
  • St. Paul's Hospital

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJAMA
Volume321
Issue number20
DOIs
StatePublished - May 28 2019

Disciplines

  • Medicine and Health Sciences
  • Internal Medicine

Cite this